Home What we do Services Product Launch

Product Launch.

Simplifying launch complexities by combining skilled project leaders with a proven product launch framework customized to maximize outcomes.


New-to-market product launches with our support


Therapy areas supported


Rare disease areas supported within the launch space


Product launch engagements since the beginning of 2016


Launch clients served


Vynamic team members have led or supported product launch planning

About Product Launch.

Launching a product, whether your first or a new indication, is exciting but incredibly complex. Successfully navigating a launch – from pre-commercialization to regulatory approval and beyond – relies on many moving parts and close collaboration between teams and different business areas.

Combining vast experience and expertise, Vynamic can simplify the product launch journey across multiple stages, providing a structured yet flexible approach that supports you across functions or takes a focused, deep dive into a specific area or process. However you want to work, the result is an optimized launch program that creates efficiencies, minimizes risk, and ensures product success.

Ashley Stanley

Executive, Product Launch Service Lead, & Durham Hub Lead

Brian Stamm

Executive & Product Launch Service Lead

Let’s talk.

At Vynamic, we’re experienced across a broad range of launches, providing expert guidance and hands-on support required to maximize success with your life science product launch strategy. Get in touch to understand how we can partner with you to achieve your launch goals.

Get in touch

The evolution of Product Launch.

Over the years, Vynamic has experienced first-hand how product launch strategy and operational execution have evolved. This evolution is in part due to five key trends affecting Life Sciences organizations and the healthcare industry at large.

Our Life Sciences expertise.

Our goal is to provide a better way for Life Sciences companies to create real, lasting change on human health. Tap below to learn more about the work we do across Life Sciences – in addition to our product launch capabilities.

We’ve provided product launch support across many therapy areas:


  • Cardiovascular Disease
  • Chronic Kidney Disease
  • Diabetes
  • Lupus Nephritis


  • Biliary cancer
  • Bladder cancer
  • Blood cancer / Hematology
  • Breast cancer
  • Carcinoma cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Kidney cancer
  • Liver cancer
  • Lung cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Renal cancer

Rare Disease

  • Beta Thalassemia
  • Blood Cancer
  • Chronic ITP
  • Dengue Disease
  • Dermatomyositis
  • Endometrial Cancer
  • Eosinophilic Esophagitis
  • Hemochromatosis
  • Hyperkalemic
  • Idiotic Hypersomnia
  • Lung Cancer
  • Multiple Myeloma
  • Myelofibrosis
  • Narcolepsy
  • Ovarian Cancer
  • Short Bowel Syndrome
  • Sickle Cell Disease
  • Spinal Muscular Atrophy
  • Transthyretin (TTR) Amyloidosis


  • Asthma
  • COPD
  • Influenza
  • Respiratory Syncytial Virus


  • HPV Vaccines
  • mRNA Vaccines
  • Pneumococcal Vaccines


  • ADHD
  • Alzheimer’s
  • Chronic Iron Overload
  • Crohn’s Disease
  • Dermatomyositis
  • Dry-Eye Disease
  • Gene Therapy
  • Geographic Atrophy
  • Insomnia
  • Liver Disease
  • Medical Cannabis
  • NASH (Nonalcoholic Steatohepatitis)
  • Ophthalmia
  • Osteoarthritis
  • Osteoporosis
  • Ulcerative Colitis

Global markets.

Vynamic has helped support launch readiness efforts in several global markets including Australia, Brazil, Canada, China, France, Germany, Italy, Japan, United Kingdom, United States, Spain and Switzerland.